propublica.org · 14 min
ProPublica's data analysis shows that since Texas banned abortion, more women have nearly bled to death during miscarriages because doctors hesitate to perform D&C procedures, which are also used for abortion.
Saturday · 2026
6 stories · 6 outlets · 4 min read
New data ties Texas's abortion ban to a dangerous rise in severe bleeding during miscarriages. Meanwhile, a parasitic outbreak in Michigan is growing, and aging research is buzzing about cellular reprogramming.
In today's edition: Abortion ban fallout, Outbreaks and heat and Aging tech and wearables, plus quick bites.
Propublica, Abcnews, Technologyreview and 3 more
The most consequential health story today is a data-driven look at how Texas's abortion restrictions are endangering women during miscarriages.
propublica.org · 14 min
ProPublica's data analysis shows that since Texas banned abortion, more women have nearly bled to death during miscarriages because doctors hesitate to perform D&C procedures, which are also used for abortion.
Two public health threats are making headlines: a parasitic infection in Michigan and a dangerous heat wave for the holiday weekend.
abcnews.com · 4 min
Michigan is seeing a cyclosporiasis outbreak with over 300 cases, far above the usual annual count of about 50. The parasite spreads via contaminated food or water, and officials are still hunting for the source.
kgou.org · 3 min
A stagnant heat wave is settling over the central U.S. for July 4th, with heat indices reaching 109°F in parts of Oklahoma. The National Weather Service warns it will last several days.
Longevity science and consumer health tech both had notable updates today, from reprogramming hype to Samsung pulling a feature.
technologyreview.com · 3 min
MIT Technology Review explains why cellular reprogramming is the hottest approach in aging research right now, driven by promising mouse studies and big funding, but human applications are still distant.
sammobile.com · 4 min
Samsung is removing the experimental Vascular Load feature from Galaxy Watches in the U.S., likely due to FDA clearance issues, and replacing it with a Blood Pressure Trend feature.
Wednesday
Health · 6 stories